Glypican-4 enhances insulin signaling via interaction with the insulin receptor and serves as a novel adipokine

Diabetes

Volumn 61, Issue 9, 2012, Pages 2289-2298

  Ussar, Siegfried ^a   Bezy, Olivier ^a   Blüher, Matthias ^b   Kahn, C Ronald ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; CCAAT ENHANCER BINDING PROTEIN DELTA; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; GLYPICAN; GLYPICAN 4; INSULIN; INSULIN RECEPTOR; MESSENGER RNA; MUTANT PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BODY MASS; BROWN ADIPOSE TISSUE; CELL DIFFERENTIATION; CONTROLLED STUDY; EXPLANT; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; MALE; MASS SPECTROMETRY; METABOLIC PARAMETERS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; WEIGHT GAIN; WESTERN BLOTTING; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; GLYPICANS; HUMANS; INTRA-ABDOMINAL FAT; MICE; RECEPTOR, INSULIN;

EID: 84865469865     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-1395     Document Type: Article

References (32)

1. Gesta S, Tseng YH, Kahn CR. Developmental origin of fat: tracking obesity to its source. Cell 2007;131:242-256 (Pubitemid 47576146)
2. Tran TT, Yamamoto Y, Gesta S, Kahn CR. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 2008;7:410-420 (Pubitemid 351598027)
3. Butterwith SC. Regulators of adipocyte precursor cells. Poult Sci 1997;76:118-123 (Pubitemid 127518623)
4. Blüher M, Michael MD, Peroni OD, et al. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev Cell 2002;3:25-38 (Pubitemid 34778393)
5. Deng Y, Scherer PE. Adipokines as novel biomarkers and regulators of the metabolic syndrome. Ann N Y Acad Sci 2010;1212:E1-E19
6. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000;11:327-332
7. Kralisch S, Bluher M, Paschke R, Stumvoll M, Fasshauer M. Adipokines and adipocyte targets in the future management of obesity and the metabolic syndrome. Mini Rev Med Chem 2007;7:39-45 (Pubitemid 46062372)
8. Gesta S, Bluher M, Yamamoto Y, et al. Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc Natl Acad Sci USA 2006;103:6676-6681
9. De Cat B, David G. Developmental roles of the glypicans. Semin Cell Dev Biol 2001;12:117-125
10. Fico A, Maina F, Dono R. Fine-tuning of cell signaling by glypicans. Cell Mol Life Sci 2011;68:923-929
11. Filmus J, Capurro M, Rast J. Glypicans. Genome Biol 2008;9:224
12. Karumanchi SA, Jha V, Ramchandran R, et al. Cell surface glypicans are low-affinity endostatin receptors. Mol Cell 2001;7:811-822 (Pubitemid 32436441)
13. Hagihara K, Watanabe K, Chun J, Yamaguchi Y. Glypican-4 is an FGF2-binding heparan sulfate proteoglycan expressed in neural precursor cells. Dev Dyn 2000;219:353-367
14. Bezy O, Vernochet C, Gesta S, Farmer SR, Kahn CR. TRB3 blocks adipocyte differentiation through the inhibition of C/EBPbeta transcriptional activity. Mol Cell Biol 2007;27:6818-6831 (Pubitemid 47483632)
15. Woods A, Couchman JR. Proteoglycan isolation and analysis. Curr Protoc Cell 2001;10.7.1-10.7.19
16. Grunfeld C, Van Obberghen E, Karlsson FA, Kahn CR. Antibody-induced desensitization of the insulin receptor. Studies of the mechanism of desensitization in 3T3-L1 fatty fibroblasts. J Clin Invest 1980;66:1124-1134 (Pubitemid 11233814)
17. Farmer SR. Transcriptional control of adipocyte formation. Cell Metab 2006;4:263-273 (Pubitemid 44430910)
18. Zhang YY, Li X, Qian SW, et al. Transcriptional activation of histone H4 by C/EBPb during the mitotic clonal expansion of 3T3-L1 adipocyte differentiation. Mol Biol Cell 2011;22:2165-2174
19. Park BH, Qiang L, Farmer SR. Phosphorylation of C/EBPbeta at a consensus extracellular signal-regulated kinase/glycogen synthase kinase 3 site is required for the induction of adiponectin gene expression during the differentiation of mouse fibroblasts into adipocytes. Mol Cell Biol 2004;24:8671-8680 (Pubitemid 39245086)
20. Traister A, Shi W, Filmus J. Mammalian Notum induces the release of glypicans and other GPI-anchored proteins from the cell surface. Biochem J 2007;410:503-511 (Pubitemid 351429021)
21. Klöting N, Fasshauer M, Dietrich A, et al. Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 2010;299:E506-E515
22. Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 2004;89:2595-2600 (Pubitemid 38766337)
23. Brunner G, Metz CN, Nguyen H, et al. An endogenous glycosylphosphatidylinositol- specific phospholipase D releases basic fibroblast growth factor-heparan sulfate proteoglycan complexes from human bone marrow cultures. Blood 1994;83:2115-2125 (Pubitemid 24112722)
24. Raikwar NS, Bowen-Deeg RF, Du XS, Low MG, Deeg MA. Glycosylphosphatidylinositol- specific phospholipase D improves glucose tolerance. Metabolism 2010;59:1413-1420
25. Saltiel AR, Cuatrecasas P. In search of a second messenger for insulin. Am J Physiol 1988;255:C1-C11
26. Kurtz TA, Fineberg NS, Considine RV, Deeg MA. Insulin resistance is associated with increased serum levels of glycosylphosphatidylinositol-specific phospholipase D. Metabolism 2004;53:138-139 (Pubitemid 38168881)
27. Bowen RF, Raikwar NS, Olson LK, Deeg MA. Glucose and insulin regulate glycosylphosphatidylinositol-specific phospholipase D expression in islet beta cells. Metabolism 2001;50:1489-1492 (Pubitemid 34007423)
28. Youngren JF. Regulation of insulin receptor function. Cell Mol Life Sci 2007;64:873-891 (Pubitemid 46597750)
29. Srinivas PR, Wagner AS, Reddy LV, et al. Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level. Mol Endocrinol 1993;7:1445-1455
30. Tang QQ, Gronborg M, Huang HJ, et al. Sequential phosphorylation of CCAAT enhancer-binding protein beta by MAPK and glycogen synthase kinase 3beta is required for adipogenesis. Proc Natl Acad Sci USA 2005;102:9766-9771 (Pubitemid 40993643)
31. Miki H, Yamauchi T, Suzuki R, et al. Essential role of insulin receptor substrate 1 (IRS-1) and IRS-2 in adipocyte differentiation. Mol Cell Biol 2001;21:2521-2532 (Pubitemid 32222104)
32. Boucher J, Tseng Y H, Kahn CR. Insulin and insulin-like growth factor-1 receptors act as ligand-specific amplitude modulators of a common pathway regulating gene transcription. J Biol Chem 2010;285:17235-17245